Skip to main content

Table 2 Patients’ Characteristics

From: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series

Case

Age

PS

MIB-1 index

IDH1 Mutation

MGMT Methylation

CGH

Surgical removal

Radiation

TMZ cycles

Other treatment

1

75

1

40.1

wild

–

+ 7p15.2-qter, − 10, −15q, (−16qcen-13)

GTR

40Gy/15fr

22

–

2

39

1

11.1

wild

+

+1pter-34.1, −9pter-21, − 10q21.1-ter, +13q12.2–31, +17p12-q21.1, −18q23, −21q, +22qcen-13.1

GTR

60Gy/30fr

31

BCNU wafer

3

52

0

30

wild

–

-1pter-36.1, + 7, −9pter-21, − 10

GTR

60Gy/30fr

14

BCNU wafer

4

50

0

50

wild

+

+ 7, − 10, +12q15, +13q14.3–33

GTR

60Gy/30fr

14

–

  1. BCNU bis-chloroethylnitrosourea, CGH comparative genomic hybridization, GTR gross total resection, IDH isocitrate dehydrogenase, MGMT O6 methylguanine DNA methyltransferase, PS performance status, TMZ temozolomide